Shunzhe Zheng

机构：Shenyang Pharmaceutical University, Fujian Medical University, First Affiliated Hospital of Fujian Medical University

发表论文 23 篇 · 总被引 474 次 · h-index 12

代表论文

• Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system (2022 · Journal of Nanobiotechnology · 被引 84)
• Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy (2023 · Nature Communications · 被引 75)
• Ruthenium Single‐Atom Nanozyme Driven Sonosensitizer with Oxygen Vacancies Enhances Electron–Hole Separation Efficacy and Remodels Tumor Microenvironment for Sonodynamic‐Amplified Ferroptosis (2025 · Advanced Science · 被引 50)
• In vivo irreversible albumin-binding near-infrared dye conjugate as a naked-eye and fluorescence dual-mode imaging agent for lymph node tumor metastasis diagnosis (2019 · Biomaterials · 被引 50)
• Emerging platinum(IV) prodrug nanotherapeutics: A new epoch for platinum-based cancer therapy (2023 · Journal of Controlled Release · 被引 39)
• In situ apolipoprotein E-enriched corona guides dihydroartemisinin-decorating nanoparticles towards LDLr-mediated tumor-homing chemotherapy (2019 · Asian Journal of Pharmaceutical Sciences · 被引 32)